Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q1 FY20 results · Apr–Jun 2019
Alkem Laboratories reported revenue from operations of ₹1,849.50 crore (up 10.8% from Q1 FY19) and net profit of ₹187.29 crore (up 36.4% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,849.50 | 1,669.46 | +10.8% | 1,854.20 | −0.3% |
| Other income | 17.47 | 16.25 | +7.5% | 27.66 | −36.8% |
| Total income | 1,866.97 | 1,685.71 | +10.8% | 1,881.86 | −0.8% |
| Profit before tax | 210.02 | 171.77 | +22.3% | 198.81 | +5.6% |
| Net profit for the period | 187.29 | 137.27 | +36.4% | 170.50 | +9.8% |
| Attributable to shareholders of the company | 185.47 | 136.15 | +36.2% | 167.36 | +10.8% |
| EPS, basic (₹) | 15.51 | 11.39 | +36.2% | 14.00 | +10.8% |
| Net margin (%) | 10.1 | 8.2 | 9.2 |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,498.51 | 1,280.36 | +17.0% | 1,467.84 | +2.1% |
| Other income | 12.72 | 8.97 | +41.9% | 19.07 | −33.3% |
| Total income | 1,511.23 | 1,289.33 | +17.2% | 1,486.91 | +1.6% |
| Profit before tax | 228.56 | 157.62 | +45.0% | 214.65 | +6.5% |
| Net profit for the period | 210.62 | 129.49 | +62.7% | 190.82 | +10.4% |
| EPS, basic (₹) | 17.62 | 10.83 | +62.7% | 15.96 | +10.4% |
| Net margin (%) | 14.1 | 10.1 | 13.0 |
Consolidated
- Filed with BSE
- 13 Aug 2019, 12:47 IST
- Board meeting
- 12 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2019, 12:47 IST
- Board meeting
- 12 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE